Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Language
Year range
1.
J Biosci ; 2006 Dec; 31(5): 629-37
Article in English | IMSEAR | ID: sea-110959

ABSTRACT

Spontaneous intercellular chromatin migration/cytomixis was observed to occur in the pollen mother cells (PMCs) of the Chlorophytum comosum for the first time. The migration through cytomictic channels was more pronounced in meiosis-I and very rare in meiosis-II. The process was associated with erratic meiosis, which was characterized by defects in chromosome organization and segregation. Cytomixis was more intense in the month of April than in July and consequently the frequency of meiotic irregularities was much more pronounced during the month of April. As a consequence of abnormal meiosis, fertility was drastically reduced resulting in meager seed efficiency of 17% only. Recombination system also does not guarantee the release of sufficient variability. We view the phenomenon of cytomixis as genetically controlled mechanism involving meiotic genes and operating through signal transduction pathway triggered by the environmental stimuli. The evolutionary significance and tenable hypothesis in the backdrop of existing literature is also proposed.


Subject(s)
Asparagaceae/cytology , Chromatin/metabolism , Chromosome Segregation/physiology , Meiosis/physiology , Pollen Tube/cytology , Reproduction , Seasons , Seeds/cytology
3.
Article in English | IMSEAR | ID: sea-86357

ABSTRACT

The efficacy and safety of ondansetron was evaluated and compared with metoclopramide in 93 patients receiving cisplatin containing cancer chemotherapy in a randomized, parallel group study. 8 mg Ondansetron i.v. was administered prior to chemotherapy followed by two further doses of 8 mg i.v. over the first 24 hours. Ondansetron 8 mg b.d. was then administered orally for the next 5 days. The metoclopramide dosage was 20 mg i.v. prior to chemotherapy followed by 2 i.v. doses of 10 mg each, 4 hours apart. For the next 5 days, an oral dose of 20 mg metoclopramide was administered. The anti-emetic efficacy of ondansetron as a prophylactic treatment was found to be significantly more effective than metoclopramide both during the acute and delayed phase of nausea and vomiting. Both treatments were well tolerated with no reported side-effects.


Subject(s)
Adult , Aged , Antiemetics/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Chi-Square Distribution , Cisplatin/administration & dosage , Dose-Response Relationship, Drug , Female , Humans , Infusions, Intravenous , Male , Metoclopramide/administration & dosage , Middle Aged , Ondansetron/administration & dosage , Probability , Treatment Outcome , Vomiting/chemically induced
4.
Article in English | IMSEAR | ID: sea-91321

ABSTRACT

We evaluated harvested marrow cells for total nucleated cells (27.49 x 10(9)), absolute 'lymphocyte' count (6.29 x 10(9)) and CD 34 positive cells (3.57 x 10(9)). The same parameters were studied after in vitro manipulation to remove RBCs and plasma. Reinfused WBCs contained 12.87 x 10(9) nucleated cells, 4.25 x 10(9) absolute 'lymphocyutes' and 3.34 x 10(9) CD 34 positive cells. The corresponding figures for loss during in vitro manipulation (tubing, RBCs and plasma) are 14.62 (53.18%), 2.04 (32.43%) and 0.23 x 10(9) (6.44%) cells respectively. Therefore CD 34 positivity may be a better indicator of total yield, loss during manipulation and reinfusion of hemopoietic progenitor cells in bone marrow transplantation.


Subject(s)
Antigens, CD34/analysis , Bone Marrow Cells , Bone Marrow Examination , Bone Marrow Purging , Bone Marrow Transplantation , Cytapheresis , Erythrocytes , Female , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/cytology , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Leukocyte Count , Lymphocyte Count , Plasma , Plasmapheresis
5.
Article in English | IMSEAR | ID: sea-91224
SELECTION OF CITATIONS
SEARCH DETAIL